Because the regulator is not only judging what the numbers say. It is judging whether the organisation can prove who created them, when they were created, and whether they were altered. Without that context, even accurate data becomes difficult to defend under review.
Why This Matters for Security Teams
In pharma and biotech, metadata is not administrative clutter. It is the evidence layer that makes lab results, assay outputs, batch records, and analytics defensible under GxP review. If a record cannot show provenance, timestamps, ownership, and change history, the underlying data may still be scientifically sound but operationally weak. That is why metadata controls often sit at the intersection of quality, compliance, and security.
Current guidance from the NIST Cybersecurity Framework 2.0 reinforces that organisations need traceable governance over assets and access, not just protection of the payload. The same logic applies to non-human identities: NHI Mgmt Group’s Ultimate Guide to NHIs — Key Research and Survey Results reports that only 5.7% of organisations have full visibility into their service accounts, which is a major problem when those accounts create or modify regulated records. In practice, many security teams encounter metadata gaps only after a validation failure, data-integrity query, or audit challenge has already exposed them.
How It Works in Practice
In regulated life sciences environments, metadata is what turns a file, dataset, or transaction into evidence. That includes who generated it, what system generated it, which pipeline or instrument touched it, what time it was created, whether it was changed, and whether the change was authorised. Without that context, teams cannot reliably demonstrate integrity, lineage, or separation of duties.
Security teams should treat metadata controls as part of the identity and access model, not as a document-management afterthought. That means:
- capturing creator identity and workload identity at the point of generation
- preserving immutable timestamps and audit trails for each material change
- linking records to system, instrument, and process context
- restricting who can edit metadata fields and logging those edits separately
- retaining lineage across exports, integrations, and analytics platforms
This matters because non-human identities frequently create the most sensitive records. NHI Mgmt Group’s research notes that Schneider Electric credentials breach is an example of how identity compromise can create trust issues far beyond a single system. When metadata is tied to properly governed identities, organisations can show not only that data exists, but that it was produced and handled under controlled conditions. That is especially important for electronic batch records, laboratory information management systems, quality events, and automated analytics where machine-generated content may be reviewed later by humans or regulators. These controls tend to break down when data is copied across disconnected systems without preserved provenance because the chain of custody becomes impossible to reconstruct.
Common Variations and Edge Cases
Tighter metadata control often increases operational overhead, requiring organisations to balance auditability against speed, integration friction, and user experience. That tradeoff is real in pharma and biotech, especially where legacy instruments, contract labs, and cross-border data flows are involved.
Best practice is evolving rather than universal for some edge cases. For example, there is no universal standard for how much metadata must travel with derived analytics, model outputs, or intermediary files, but current guidance suggests preserving enough context to recreate the decision path. Likewise, when automated systems enrich records at high volume, teams need clear rules for what counts as source metadata versus derived metadata, and which fields are immutable.
Metadata also becomes harder to govern when NHIs span third parties, shared platforms, or hybrid laboratory stacks. NHI Mgmt Group reports that 96% of organisations store secrets outside of secrets managers in vulnerable locations, which increases the chance that the systems writing metadata are themselves poorly controlled. In those environments, the data record may be intact while the trust signal around it is weak. Practitioners should focus on identity provenance, change logging, and retention rules together, because metadata problems often surface only when an investigator tries to answer a question that the original system was never designed to retain.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
OWASP Non-Human Identity Top 10 address the attack and risk surface, while NIST CSF 2.0 and NIST AI RMF set the governance and control requirements practitioners need to meet.
| Framework | Control / Reference | Relevance |
|---|---|---|
| NIST CSF 2.0 | PR.DS-4 | Metadata integrity supports the ability to detect and preserve altered records. |
| OWASP Non-Human Identity Top 10 | NHI-01 | Service accounts that create metadata need strong identity governance and traceability. |
| NIST AI RMF | AI RMF addresses provenance and documentation for automated outputs used in regulated decisions. |
Protect record integrity by logging changes, preserving provenance, and verifying that regulated data is unchanged.
Related resources from NHI Mgmt Group
Deepen Your Knowledge
Reviewed and updated by the NHIMG editorial team on June 9, 2026.
NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org
